medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2018, Número 1

Rev Invest Clin 2018; 70 (1)


NOD2: Activation During Bacterial and Viral Infections, Polymorphisms and Potential as Therapeutic Target

Domínguez-Martínez DA, Núñez-Avellaneda D, Castañón-Sánchez CA, Salazar MI

Idioma: Inglés.
Referencias bibliográficas: 59
Paginas: 18-28
Archivo PDF: 628.31 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Shaw MH, Reimer T, Kim YG, Nuñez G. NOD-like receptors (NLRs): Bona fide intracellular microbial sensors. Curr Opin Immunol. 2008;20:377-82.

  2. Krishnaswamy JK, Chu T, Eisenbarth SC. Beyond pattern recognition: NOD-like receptors in dendritic cells. Trends Immunol. 2013;34:224-33.

  3. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805-20.

  4. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499-511.

  5. Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 2014;32:461-88.

  6. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005;175:2851-8.

  7. Kolakofsky D, Kowalinski E, Cusack S. A structure-based model of RIG-I activation. RNA. 2012;18:2118-27.

  8. Kanneganti T. Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol. 2010;10:688-98.

  9. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397-411.

  10. Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660-5.

  11. Ting J, Duncan J, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science. 2010;327: 286-90.

  12. Byrne BG, Dubuisson JF, Joshi AD, Persson JJ, Swanson MS. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. MBio. 2013;4: e00620-12.

  13. Lamkanfi M, Kanneganti TD. Regulation of immune pathways by the NOD-like receptor NLRC5. Immunobiology. 2012; 217:13-6.

  14. Lupfer C, Kanneganti T. Unsolved mysteries in NLR biology. Front Immunol. 2013;4:285.

  15. Keestra-Gounder AM, Byndloss MX, Seyffert N, et al. NOD1 and NOD2 signalling links ER stress with inflammation. Nature. 2016;532:394-7.

  16. Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and crohn’s disease. Mucosal Immunol. 2011;4:484-95.

  17. Lécine P, Esmiol S, Métais JY, et al. The NOD2-RICK complex signals from the plasma membrane. J Biol Chem 2007;282: 15197-207.

  18. Fritz JH, Girardin SE, Fitting C, et al. Synergistic stimulation of human monocytes and dendritic cells by toll-like receptor 4 and NOD1-and NOD2-activating agonists. Eur J Immunol. 2005;35:2459-70.

  19. Travassos LH, Girardin SE, Philpott DJ, et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004;5:1000-6.

  20. Leber JH, Crimmins GT, Raghavan S, et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 2008;4:e6.

  21. Landes MB, Rajaram MV, Nguyen H, Schlesinger LS. Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and no production in human macrophages. J Leukoc Biol. 2015;97:1111-9.

  22. Wang H, Yu G, Yu H, et al. Characterization of TLR2, NOD2, and related cytokines in mammary glands infected by Staphylococcus aureus in a rat model. Acta Vet Scand. 2015;57:25.

  23. Liu X, Han Q, Leng J. Analysis of nucleotide-binding domain oligomerization domain proteins in a murine model of pneumococcal meningitis. BMC Infect Dis. 2014;14:648.

  24. Marchesan J, Jiao Y, Schaff RA, et al. TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens. Mol Oral Microbiol. 2016;31:243-58.

  25. Prates TP, Taira TM, Holanda MC, et al. NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. J Dent Res 2014;93:1155-62.

  26. Lecat A, Piette J, Legrand-Poels S. The protein nod2: An innate receptor more complex than previously assumed. Biochem Pharmacol. 2010;80:2021-31.

  27. Hasegawa M, Fujimoto Y, Lucas PC, et al. A critical role of RICK/ RIP2 polyubiquitination in nod-induced NF-kappaB activation. EMBO J. 2008;27:373-83.

  28. Jakopin Ž. Nucleotide-binding oligomerization domain (NOD) inhibitors: A rational approach toward inhibition of NOD signaling pathway. J Med Chem. 2014;57:6897-918.

  29. Wertz IE, Dixit VM. Signaling to NF-kappaB: Regulation by ubiquitination. Cold Spring Harb Perspect Biol. 2010;2: a003350.

  30. Hsu YM, Zhang Y, You Y, et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol. 2007;8:198-205.

  31. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010; 11:55-62.

  32. Anand PK, Tait SW, Lamkanfi M, et al. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2011;286:42981-91.

  33. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90-7.

  34. Monie TP. NLR activation takes a direct route. Trends Biochem Sci. 2013;38:131-9.

  35. Coutermarsh-Ott S, Eden K, Allen IC. Beyond the inflammasome: Regulatory NOD-like receptor modulation of the host immune response following virus exposure. J Gen Virol. 2016; 97:825-38.

  36. Sabbah A, Chang TH, Harnack R, et al. Activation of innate immune antiviral responses by nod2. Nat Immunol. 2009;10:1073-80.

  37. Vissers M, Remijn T, Oosting M, et al. Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells. Eur J Immunol. 2012;42: 2727-35.

  38. Hernandez J, Giraldo D, Paul S, Urcuqui-Inchima S. Involvement of neutrophil hyporesponse and the role of toll-like receptors in human immunodeficiency virus 1 protection. PLoS One. 2015;10:e0119844.

  39. Le Bel M, Gosselin J. Leukotriene B4 enhances NOD2-dependent innate response against influenza virus infection. PLoS One. 2015;10:e0139856.

  40. Lei Q, Li L, Cai J, et al. ORF3 of hepatitis E virus inhibits the expression of proinflammatory cytokines and chemotactic factors in LPS-stimulated human PMA-THP1 cells by inhibiting NF-κB pathway. Viral Immunol. 2016;29:105-11.

  41. Lupfer C, Thomas P, Anand P, et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat Immunol. 2013;14:480-8.

  42. Lupfer C, Thomas P, Kanneganti T. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza a virus infection. J Virol. 2014;88:8946-55.

  43. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-4.

  44. Moreira LO, Zamboni DS. NOD1 and NOD2 signaling in infection and inflammation. Front Immunol. 2012;3:328.

  45. Jaskula E, Lange A, Kyrcz-Krzemien S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, et al. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:409-14.

  46. Tello-Ruiz M, Walsh E, Rioux J. Gastroenterologic and hepatic disease. Madame Curie Bioscience Database. Austin (TX): Lande Bioscience; 2000.

  47. Cantó E, Ricart E, Busquets D, et al. Influence of a nucleotide oligomerization domain 1(NOD1) polymorphim and NOD2 mutant alleles on crohn´s disease phenotype. World J Gastroenterol 2007;13:5446-53.

  48. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003;100:3455-60.

  49. Strober W, Asano N, Fuss I, Kitani A, Watanabe T. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in crohn’s disease. Immunol Rev. 2014;260: 249-60.

  50. Inohara N, Nuñez G. NODs: Intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-82.

  51. Sales-Marques C, Salomão H, Fava VM, et al. NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians. Hum Genet. 2014;133:1525-32.

  52. Grube M, Brenmoehl J, Rogler G, Hahn J, Herr W, Holler E. Donor Nucleotide-Binding oligomerization-containing protein 2 (NOD2) single nucleotide polymorphism 13 is associated with septic shock after allogenic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:1399-404.

  53. Zhang Q, Pan Y, Yan R, et al. Commensal bacteria direct selective cargo sorting to promote symbiosis. Nat Immunol. 2015;16: 918-26.

  54. Salem M, Seidelin JB, Eickhardt S, et al. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and toll-like receptor (TLR) signalling upon intracellular bacterial infection: Role of crohn’s associated NOD2 gene variants. Clin Exp Immunol. 2015;179:426-34.

  55. Franchi L, Núñez G. The nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol. 2008;38:2085-9.

  56. Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453:1122-6.

  57. Geddes K, Magalhães JG, Girardin SE. Unleashing the therapeutic potential of NOD-like receptors. Nat Rev Drug Discov. 2009;8:465-79.

  58. Kool M, Soullié T, van Nimwegen M, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med. 2008;205:869-82.

  59. Canning P, Ruan Q, Schwerd T, et al. Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors. Chem Biol. 2015;22:1174-84.




2020     |     www.medigraphic.com